Best Lung Cancer Specialists in the UK: 2026 Expert Rankings

Lung cancer remains the leading cause of cancer-related death in the United Kingdom, with more than 48,000 new cases diagnosed each year and a five-year survival rate that, while improving, still lags behind the averages seen across comparable European nations. The gap in outcomes between specialist centres and general hospitals is well-documented, which means that access to the right clinician at the right time is not merely a matter of preference. For many patients, it is a matter of survival. In this context, the ability to identify the country's finest lung cancer specialists has never carried more practical weight.

This guide profiles ten of the most accomplished lung cancer specialists currently practising in the United Kingdom, encompassing consultant clinical oncologists and consultant thoracic surgeons whose careers reflect the full breadth of the discipline. It draws on professional credentials, institutional affiliations, research output, clinical reputation, and contribution to national and international practice. Whether you are a patient newly diagnosed, a GP seeking the right referral, or a clinician assessing the landscape of expert care, this 2026 ranking offers a reliable and considered overview of where the highest standards of lung cancer treatment reside.

What Sets a Leading Lung Cancer Specialist Apart

Identifying genuine excellence in lung cancer care requires looking across several dimensions at once. Clinical outcomes, including resection rates, post-operative mortality, recurrence patterns, and long-term survival data, offer the most objective measurement of a surgeon or oncologist's performance over time. In a specialty where the margin between curative and palliative intent can rest on a single staging decision or a nuanced understanding of tumour biology, this kind of performance data carries significant weight. The most accomplished clinicians are those who consistently deliver results that exceed both institutional and national benchmarks.

Equally important is the breadth of each clinician's engagement with the wider field. The finest lung cancer specialists are invariably those who contribute to national audits, participate in or lead clinical trials, author guidelines, and invest actively in the training of the next generation of practitioners. They do not merely apply the evidence; they help to build it. Alongside these professional markers, a commitment to patient-centred care distinguishes the best in the field, encompassing clear and compassionate communication, seamless coordination across multidisciplinary teams, and an unwavering orientation toward treating the whole person rather than the tumour alone.

1. Dr. James Wilson

Oxford-Trained Oncologist With a Distinguished Academic Foundation

Dr. James Wilson is a Consultant Clinical Oncologist specialising in thoracic malignancies, whose training places him in exceptionally rare professional company. He read medicine at the University of Oxford, undertook specialist oncology training at The Royal Marsden Hospital, one of the world's foremost cancer centres, and completed a fellowship at Massachusetts General Hospital in Boston, a global institution synonymous with clinical and research excellence. He subsequently served as a Consultant at University College London Hospitals and as an Honorary Associate Professor at UCL, where he combined specialist clinical practice with academic teaching and research. His qualifications include a DPhil from Oxford, Fellowship of the Royal College of Radiologists, Membership of the Royal College of Physicians, Fellowship of the Royal Society of Medicine, Fellowship of the International Cardio-Oncology Society, and Fellowship of the International Thymic Malignancy Interest Group, a credential profile that is as broad as it is distinguished.

A Precision Medicine Philosophy Rooted in the Individual

What distinguishes Dr. Wilson most clearly from many of his contemporaries is a clinical philosophy anchored in radical personalisation. Rather than applying standardised pathways, he engages deeply with the molecular profile, staging, and personal circumstances of each patient before constructing a treatment plan. In 2025, he made the deliberate decision to focus exclusively on private practice, enabling him to dedicate more consultation time to each patient and ensure rapid access to advanced treatments that may not be readily available through standard referral routes. His approach is articulated in a mission statement that speaks directly to the human dimension of oncology: to understand who the patient was before their diagnosis and to restore that person as fully and as quickly as possible.

Expertise Across Advanced Radiotherapy and Systemic Treatment

Dr. Wilson's clinical toolkit is broad and forward-looking. His expertise in stereotactic ablative radiotherapy (SABR) gives him a powerful means of delivering curative-intent treatment to patients who are not surgical candidates, including those with early-stage disease, limited pulmonary reserve, or tumours in anatomically challenging locations. He is additionally experienced in proton beam therapy, a cutting-edge radiotherapy modality available at only a small number of UK centres, as well as chemotherapy and immunotherapy regimens. This integration of high-precision radiotherapy with systemic oncology strategy gives him a full-spectrum perspective that relatively few single clinicians can offer. His specialist interest also extends to mesothelioma, thymoma, and oligometastatic disease, encompassing rarer thoracic malignancies where clinical judgment carries especially significant weight.

Trusted by Peers and Patients Alike

Beyond the consultation room, Dr. Wilson is consistently described by patients and referring clinicians as a practitioner of exceptional intellectual clarity and genuine compassion. He works across leading London institutions including the Cromwell Hospital, Icon Cancer Centre, Proton Therapy London, GenesisCare, and Nuffield Health, a breadth of institutional presence that reflects both the demand for his expertise and his fluency across the full range of treatment modalities available in modern UK oncology. He also provides detailed second opinions for complex cases, identifying additional treatment strategies, access to clinical trials, and novel therapies tailored to the individual biology of each patient's cancer. For those navigating a difficult diagnosis and seeking the most expert and personalised guidance available, Dr. James Wilson represents the gold standard of lung cancer oncology in the United Kingdom.

2. Mr. Vladimir Anikin

A Career of Unmatched Depth at a World-Leading Centre

Professor Vladimir Anikin is a Consultant Thoracic Surgeon at Harefield Hospital, part of Royal Brompton and Harefield NHS Foundation Trust, one of the most prestigious cardiothoracic centres in the world. With close to five decades of experience across multiple healthcare systems, including training at some of Europe's most distinguished thoracic institutions before his move to the UK, he brings an extraordinary depth of surgical knowledge to the management of lung cancer and complex thoracic disease. His listing with Guy's and St Thomas' Specialist Care further extends the institutional footprint within which his expertise is deployed.

Specialist in Locally Advanced and Complex Resections

Professor Anikin's surgical interests include lung cancer, oesophageal cancer, tracheal stenosis, and thoracoscopic surgery, with a particular reputation for successfully operating on cases of significant anatomical complexity and locally advanced tumour involvement. His expertise in chest wall reconstruction and surgery for tumours that would be considered inoperable at most other centres has made him a trusted point of referral for some of the country's most challenging cases. For patients who have been told elsewhere that surgical options are limited, his willingness to engage with the most technically demanding presentations is professionally and personally defining.

Published Researcher With an International Citation Record

Professor Anikin maintains a substantial body of peer-reviewed publications, with over a thousand citations spanning lung cancer surgery, minimally invasive techniques, and clinical outcomes in thoracic oncology. His contributions to the academic literature have shaped understanding across multiple dimensions of thoracic surgical practice and reflect a career built not solely on clinical service but on advancing the collective knowledge of the specialty.

A Surgeon Whose Precision Defines Every Encounter

Colleagues and patients consistently describe Professor Anikin as a clinician of exceptional surgical precision and composure. His approach combines meticulous pre-operative planning with a comprehensive understanding of the entire surgical episode, from the initial assessment of operability through to post-operative recovery. For patients navigating a complex lung cancer diagnosis and weighing advanced surgical options, access to Professor Anikin represents access to some of the most experienced and respected hands in UK thoracic surgery.

3. Miss Susannah Love

A Thoracic Surgeon of Distinction at One of the UK's Busiest Specialist Units

Miss Susannah Love is a Consultant Thoracic Surgeon at Liverpool Heart and Chest Hospital, one of the largest and most active thoracic surgical units in the United Kingdom. Her clinical reputation has been built across a sustained career in a high-volume centre, where the breadth and complexity of the caseload require consistent surgical excellence and considerable personal resilience. Recognised publicly as Employee of the Month at LHCH in December 2018, that acknowledgement captured qualities that her colleagues and patients encounter every day: rigour, personal dedication, and an ability to deliver outstanding outcomes under pressure. In a unit that operates at the leading edge of UK thoracic practice, those qualities are tested continuously and consistently validated.

Surgical Expertise in Lung Cancer and Thoracic Oncology

Miss Love's specialist interests span lung cancer surgery, oesophageal cancer, and the management of a broad range of thoracic conditions, giving her a clinical profile that encompasses the full scope of thoracic surgical practice at a tertiary referral centre. She has been involved in the introduction of laser-assisted lung cancer surgery at LHCH, a technically advanced procedure that improves the precision of surgical intervention and enhances the recovery profile for patients undergoing thoracic resection. Her role in bringing this technique to the Liverpool programme reflects a professional orientation toward surgical innovation that benefits patients directly and contributes to the national evolution of the field.

Part of a World-Class Multidisciplinary Environment

LHCH has established itself as a centre of genuine national distinction in thoracic surgery, and Miss Love's contribution to that reputation is substantive. Operating within a team that includes several other consultants featured in this ranking, she benefits from and contributes to a culture of collaborative clinical excellence that elevates patient outcomes beyond what any individual clinician, however skilled, could achieve independently. Her engagement with research activity and clinical audit aligns with the hospital's institutional commitment to evidence-based practice and systematic improvement across all dimensions of patient care.

Compassionate Care That Extends Well Beyond the Operating Theatre

Patients and colleagues consistently describe Miss Love's practice as combining technical precision with exceptional interpersonal qualities. In the high-stakes context of thoracic oncology, where diagnoses carry profound emotional weight and where patients are often required to absorb complex information rapidly and under duress, her ability to communicate with clarity, honesty, and genuine warmth sets her apart. For patients in the North West of England seeking surgical expertise of the highest order, Miss Susannah Love represents one of the most trusted and accomplished clinicians available.

4. Mr. Doug West

National Audit Leadership and Institutional Excellence

Mr. Doug West is a Consultant Thoracic Surgeon at University Hospitals Bristol and Weston NHS Foundation Trust, where he has practised since 2011, and serves as Deputy Clinical Lead for Surgery at the National Lung Cancer Audit, the primary vehicle through which the quality of lung cancer care is measured and publicly reported across England and Wales. His central role within this national programme speaks directly to the esteem in which he is held by the thoracic surgery community. He additionally serves as GIRFT (Getting it Right First Time) cardiothoracic lead, contributing to systematic quality improvement efforts that extend well beyond the boundaries of his own institution.

Minimally Invasive Surgery and Peer-Reviewed Contribution

Mr. West's clinical practice centres on minimally invasive thoracic surgery, encompassing video-assisted thoracoscopic approaches that reduce recovery time, post-operative pain, and hospital stay for patients undergoing lung resection. His advocacy for these techniques has helped to shape their integration into Bristol's thoracic surgical programme, and his national audit role means that his understanding of how lung cancer surgery is performed and measured across the UK is unusually comprehensive. He is a regular contributor to the peer-reviewed literature, with publications co-authored alongside some of the most prominent names in UK thoracic surgery.

A Dual Role That Amplifies Clinical Impact

At University Hospitals Bristol, Mr. West operates within and helps to lead a thoracic surgery service known for its strong outcomes data and patient-focused culture. His simultaneous role as a practising surgeon and a national audit figure means that his clinical decisions are continuously informed by a comprehensive picture of practice quality across the entire country, a perspective that the vast majority of consultant thoracic surgeons simply do not possess. Referring physicians in the South West regard him as one of the most knowledgeable and approachable consultants for complex lung cancer cases.

Standards That Extend Nationally

Mr. West's career is distinguished by a sustained commitment to the systemic dimensions of thoracic surgery quality, not only within his own unit but across the national landscape. For patients in Bristol and beyond, his combination of surgical expertise and deep institutional influence at a national level offers a rare assurance that their care is aligned with the very best that UK lung cancer surgery can provide.

5. Mr. Francesco Di Chiara

Pioneer of Single-Incision Keyhole Surgery at Oxford

Mr. Francesco Di Chiara is a Consultant Thoracic Surgeon at the John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, where he is credited with introducing uniportal VATS surgery to the programme. This innovation enables complex lung resections to be performed through a single small incision, substantially reducing the physical burden of surgery and representing a technically demanding advance that relatively few UK surgeons have mastered. Mr. Di Chiara's role in establishing this technique at one of the country's most respected academic medical centres is a clear marker of surgical ambition and technical distinction, and his standing as one of the leading exponents of minimally invasive thoracic surgery in the UK is well-founded in both credentials and clinical record.

International Training and Distinguished Academic Credentials

Mr. Di Chiara qualified from the world-renowned Padua Medical School and undertook extensive surgical training across cardiac, thoracic, and transplantation surgery before establishing his UK consultant practice in 2016. His credentials include a Master of Surgery in Thoracic Surgery with Honours, the European Fellowship in Thoracic Surgery, and an MD, a combination that reflects both academic rigour and surgical breadth. His three-year experience as a cardiopulmonary retrieval transplant fellow adds a further dimension to an already exceptional surgical repertoire, situating his expertise within the full continuum of cardiothoracic care rather than the narrower confines of purely elective thoracic surgery.

Specialist Focus in Lung Cancer, Sarcoma, and Chest Wall Surgery

Mr. Di Chiara's specialist interests encompass lung cancer, sarcoma, chest wall surgery, and thoracic outlet syndrome, a breadth of focus that enables him to manage the full spectrum of complex thoracic oncological presentations. His involvement with Oxford University Hospitals places him within one of the UK's leading academic medical environments, where clinical practice is closely integrated with research and where the most challenging referrals from across the region regularly arrive. His private practice at Nuffield Health extends that expertise to patients seeking premium care outside the NHS, ensuring that access to his abilities is not limited by a single referral pathway.

A Clinician Defined by the Pursuit of the Technically Possible

A consistent theme throughout Mr. Di Chiara's career is the pursuit of surgical innovation as a means of improving patient outcomes. His introduction of uniportal VATS at Oxford, his transplantation background, and his engagement with complex chest wall and sarcoma cases collectively define a clinician who is not merely skilled within established parameters but actively committed to expanding them. For patients whose lung cancer presents with unusual complexity or whose circumstances demand a surgeon of genuine technical distinction, Mr. Francesco Di Chiara represents one of the finest options available anywhere in the United Kingdom.

6. Mr. Tim Batchelor

The Principal Author of the International ERAS Guidelines for Lung Cancer Surgery

Mr. Tim Batchelor is a Consultant Thoracic Surgeon whose influence on the global practice of lung cancer surgery extends well beyond his own operating list. He is the Thoracic Surgery Lead for the ERAS Society and the principal author of the international Enhanced Recovery After Surgery (ERAS) guidelines for lung cancer, a set of evidence-based recommendations now used to inform perioperative practice at specialist centres around the world. Having graduated from Edinburgh University Medical School in 1995 and trained in cardiothoracic surgery across Scotland and Yorkshire, he brings deep UK roots alongside a genuinely international professional footprint.

From Bristol Royal Infirmary to Barts Thorax Centre

Mr. Batchelor spent fifteen years as a Consultant Thoracic Surgeon at Bristol Royal Infirmary before joining the Barts Thorax Centre at Barts Health NHS Trust in 2022, where he continues to practise with a focus on lung cancer surgery, video-assisted thoracoscopic procedures, and lung volume reduction. This transition from one of the UK's most respected regional thoracic units to one of London's flagship centres reflects a career of sustained ambition and continuing professional development. His role as Lung Volume Reduction lead at Barts adds a further clinical dimension of growing importance to patients managing the intersection of lung cancer and advanced COPD.

Research Output That Shapes Global Perioperative Practice

Mr. Batchelor's research output spans surgical technique, functional evaluation of lung cancer patients, and the science of perioperative care, with contributions to major academic journals and international conference platforms including ESTS and BTOG. His involvement in the ERAS Society's thoracic working group has enabled him to translate research into clinical guidelines at a global scale, benefiting not only the patients he treats directly but the broader population of lung cancer patients worldwide whose clinicians follow recommendations he has helped to write.

Perioperative Excellence as a Defining Commitment

For patients undergoing lung cancer surgery, the quality of perioperative care surrounding the operation is as consequential as the procedure itself. Mr. Batchelor's career-long focus on enhanced recovery, reduced complication rates, and streamlined post-operative pathways means that his patients benefit from best-in-class supportive care before, during, and after their surgical intervention. His combination of technical surgical skill and rigorous scientific contribution makes him one of the most complete thoracic surgery figures practising in the United Kingdom today.

7. Mr. Julius Asante-Siaw

Clinical Lead and National Innovator at Liverpool Heart and Chest Hospital

Mr. Julius Asante-Siaw is a Consultant Thoracic Surgeon and Clinical Lead for Thoracic Surgery at Liverpool Heart and Chest Hospital, a position that places him at the helm of one of the busiest and most respected specialist thoracic units in the United Kingdom. His leadership of the surgical team at LHCH has been accompanied by a sustained commitment to innovation and quality improvement that has directly shaped the hospital's standing in national and international thoracic surgery circles. He has also appeared on the BBC's Hospital documentary series, a platform that brought his work to a broad public audience and underscored both the clinical distinction of LHCH and his own commitment to transparency in healthcare.

Pioneering Advanced Surgical Technologies in Thoracic Oncology

Mr. Asante-Siaw was instrumental in performing the first laser-assisted lung cancer surgery at LHCH and was part of the team that conducted the first UK use of Ethicon's Echelon 3000 surgical stapling devices. These milestones represent meaningful advances in the technical options available to patients and demonstrate a clinical philosophy that treats the adoption of well-evidenced new technologies as a professional imperative. His willingness to operate at the frontier of what is surgically achievable is matched by an equal commitment to safety, rigour, and patient welfare throughout the process.

A Comprehensive Surgical Repertoire Across Thoracic Disease

Mr. Asante-Siaw's areas of clinical practice encompass the full range of thoracic surgical interventions, with a particular focus on lung cancer and chest malignancies where surgical precision and technical versatility are paramount. Registered with the Society for Cardiothoracic Surgery in Great Britain and Ireland and recognised by BUPA Finder, he is accessible to patients across both NHS and private pathways, ensuring that the high standard of care his expertise delivers is not restricted by the route through which a patient arrives. His clinical scope, combined with the exceptional resources of LHCH, makes him one of the most comprehensively equipped thoracic surgeons in the country.

Leadership That Builds Institutional Excellence

As Clinical Lead, Mr. Asante-Siaw carries responsibilities that extend well beyond his personal operating list. His oversight of a large and high-performing surgical team, his engagement with audit and systematic quality improvement, and his readiness to embrace and share emerging techniques all point to a clinician equally invested in the development of the specialty as in his own clinical achievements. Trainees and colleagues at LHCH consistently describe his leadership as both intellectually demanding and genuinely supportive, a combination that produces the conditions for sustained institutional excellence and an environment in which the next generation of thoracic surgeons is shaped to the highest possible standard.

8. Mr. Joel Dunning

One of the UK's Most Cited Thoracic Surgeons

Mr. Joel Dunning is a Consultant Cardiothoracic Surgeon at James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, in Middlesbrough, and one of the most academically productive thoracic surgeons in the United Kingdom. With more than 5,800 citations and 157 peer-reviewed publications spanning lung cancer surgery, video-assisted thoracoscopic surgery (VATS) lobectomy, thymectomy, and evidence-based practice in cardiothoracic surgery, his academic profile is exceptional by any standard. His comparative research on the outcomes of VATS versus open lobectomy in early-stage lung cancer has been widely cited and has directly informed national and international surgical decision-making.

Evidence-Based Practice as an Organising Principle

Mr. Dunning's commitment to evidence-based surgery is a defining feature of his career. His engagement with the Cardiothoracic Surgery Network and his contributions to international academic conversations reflect a clinician who views clinical practice and research as genuinely inseparable endeavours. For patients at James Cook University Hospital, this commitment means that surgical decisions are made with a depth of rigour and transparency that is not universally available. His willingness to engage with public communication channels further reflects a commitment to improving public understanding of lung cancer and the surgical options available to patients.

A Minimally Invasive Programme Built on Strong Outcomes

At James Cook University Hospital, Mr. Dunning has developed a cardiothoracic surgery programme known for its adoption of minimally invasive techniques and its consistent patient outcomes. His team's work in VATS lobectomy has received international recognition, and his career has included collaborative engagement with leading European and American institutions that keep his practice connected to global developments in the field.

Influence That Reaches Well Beyond Middlesbrough

Within thoracic surgery, Mr. Dunning's name commands wide respect for his dual contribution as a technically accomplished operating surgeon and a disciplined generator of reliable clinical evidence. Patients in the North East benefit directly from his expertise, while the wider surgical community benefits from the standards of rigour and innovation that his publication record and institutional leadership have helped to establish. His career offers a compelling example of what it means to be both an excellent clinician and a meaningful contributor to the long-term progress of a surgical specialty.

9. Miss Elizabeth Belcher

Oxford Thoracic Surgery: Where Clinical Excellence Meets Academic Rigour

Miss Elizabeth Belcher is a Consultant Thoracic Surgeon at Oxford University Hospitals NHS Foundation Trust, working from the John Radcliffe Hospital, one of the UK's most distinguished academic medical centres. Holding a PhD alongside her MRCP and FRCS (CTh), she brings to her practice a clinical scientist's orientation alongside surgical expertise, a combination that produces not only technically accomplished care but a continuous critical engagement with how that care can be improved. Her listing as a faculty member by the European Association for Cardio-Thoracic Surgery acknowledges a professional standing that extends well beyond the UK and reflects a career that has earned the respect of peers internationally.

Published Research That Challenges National Practice Standards

Miss Belcher's 2021 paper in BMJ Open Respiratory Research, examining optimal resection rates for lung cancer in the UK, made a meaningful contribution to national conversations about surgical access and equity. Her conclusion that optimal resection rates may not have been reached even at high-performing UK centres is the kind of finding that challenges complacency and drives systemic improvement across the specialty. This willingness to interrogate standard practice from within the profession reflects the independence of thought and intellectual confidence that characterise the finest clinical researchers in any field.

Minimally Invasive Surgery and a Structured Follow-Up Programme

Miss Belcher's clinical practice is focused on the surgical management of thoracic malignancies, with a specialist interest in minimally invasive thoracic surgery. She has been instrumental in developing Oxford's CT follow-up programme following lung cancer surgery, a structured post-operative surveillance pathway designed to identify treatable recurrences and new primary lung tumours at the earliest possible stage. Research from Oxford demonstrated that CT-based follow-up identifies a meaningful proportion of patients with radically treatable new primary tumours, validating the clinical importance of this systematic approach and Miss Belcher's role in its establishment.

A Researcher and Clinician of Genuine Intellectual Independence

Miss Belcher's career represents a thoughtful and sustained integration of surgical practice and clinical science. Her engagement with EACTS, her SCTS registration, and her active research programme across resection rates, minimally invasive technique, and post-operative surveillance collectively define a clinician whose influence on the quality of lung cancer surgery extends far beyond her personal operating list. For patients in the South of England seeking surgical care that combines technical precision with research-driven clinical judgment, she is one of the most compelling options available.

10. Mr. Mike Shackcloth

Award-Winning Expertise and Sustained Academic Contribution

Mr. Mike Shackcloth is a Consultant Thoracic Surgeon at Liverpool Heart and Chest Hospital, where he has built a career that is as distinguished for its contribution to surgical training as it is for his personal clinical record. In 2024, he was awarded the national Golden Lungs Trainer Award, a recognition specifically honouring excellence in the training and development of the next generation of thoracic surgeons. This award speaks to a professional commitment that extends well beyond his own practice, reflecting an investment in the future of the specialty that is at least as significant as his considerable individual clinical achievements.

Lung Cancer Surgery, Minimally Invasive Techniques, and Innovation

Mr. Shackcloth's specialist interests include lung cancer surgery, oesophageal cancer, metastasectomy, and lung volume reduction therapy for patients with COPD, a scope that enables him to manage complex oncological and non-oncological thoracic presentations with equal confidence. His ongoing advocacy for CT screening as a tool for early lung cancer detection reflects a broad engagement with the preventive and diagnostic dimensions of the disease. Alongside Mr. Julius Asante-Siaw, he was among the first surgeons in the UK to use Ethicon's Echelon 3000 devices, demonstrating a consistent willingness to pioneer new surgical technologies in the service of improved patient outcomes.

A Research Record of Exceptional Scale

Mr. Shackcloth's research record is impressive by any professional measure, with over 150 works and more than 9,100 citations spanning multi-centre clinical trial outcomes, minimally invasive surgical techniques, and the management of primary lung cancer across the UK healthcare system. This volume of cited work places him among the most academically influential consultant thoracic surgeons currently practising in the country. His contributions to the national portfolio of thoracic surgery training and his active membership of leading professional bodies reflect a career that combines individual clinical excellence with genuine national impact.

A Benchmark of Commitment in One of the UK's Premier Thoracic Programmes

Within LHCH, Mr. Shackcloth's role extends from direct patient care to the broader culture of clinical quality that has made the hospital's thoracic surgery programme a point of national reference. His combination of surgical expertise, research productivity, and award-recognised dedication to training produces a clinician whose influence on lung cancer outcomes in the North West, and through the surgeons he mentors, far beyond it. For patients seeking a thoracic surgeon who is simultaneously technically accomplished and genuinely invested in the long-term advancement of the specialty, Mr. Mike Shackcloth sets a standard that is difficult to surpass.

Where World-Class Lung Cancer Expertise Meets Personalised Care

Lung cancer care in the United Kingdom has never been more capable, and the specialists profiled in this ranking represent the very best of a remarkably accomplished and dynamic field. What unites them is not merely technical skill or professional recognition but a shared commitment to advancing treatment, improving outcomes, and placing the patient at the centre of every clinical decision. The full spectrum of expertise represented here, from the most precise radiotherapy modalities to the most technically demanding minimally invasive resections, reflects a specialty that continues to evolve rapidly and in meaningful directions for patients. For anyone navigating a lung cancer diagnosis, engaging with a recognised specialist of this calibre is one of the most consequential and empowering steps available, and as this list demonstrates, the quality of expert care accessible within the UK is among the finest in the world.